Modine Manufacturing Company vs TransMedics Group Inc — how do they compare? Modine Manufacturing Company trades at $245.92 (market cap $12.18B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Modine Manufacturing Company is far larger — about 4.8× TransMedics Group Inc's market cap, and Modine Manufacturing Company is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| MOD | TMDX | |
|---|---|---|
Market Cap | $12.18B | $2.54B |
Sector | Technology | Technology |
52-Week High | $306.89 | $150.42 |
52-Week Low | $93.71 | $61.99 |
Enterprise Value | $12.54B | $2.94B |
Signals from Pluang's Aura AI — not financial advice
MOD trades at $227.88, down 0.64% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.71 exceeding expectations. Revenue reached $2.58B in 2025, though net income margin is modest at 3.82%. Recent news includes institutional buying and executive appointments, while technical support sits near $221.
Analyst consensus is bullish with a $328.80 price target, but high P/E of 101.48 suggests premium valuation. Risks include margin pressure from supply chain challenges and competitive threats in data center cooling. The stock offers growth potential if margin expansion continues, but investors face volatility from technical weakness and execution risks.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →